Would CCK-4 challenges be useful to predict anti-anxiety effects of non anti-panic drugs?

By Boulenger J.P.   Jerabek I.   Cocirc teacute G.   Lavalleacute e Y.J.   Jolicoeur F.B.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 374-375

Elsevier

Access to resources Recommend Favorite

Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model

By Lodzki M.   Godin B.   Rakou L.   Mechoulam R.   Gallily R.   Touitou E.  

Journal of Controlled Release, Vol. 93, Iss. 3, 2003-12 ,pp. : 377-387

Elsevier

Access to resources Recommend Favorite

The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5113-5130

Bentham Science Publishers

Access to resources Recommend Favorite

Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells

By Ramer Robert   Rohde Anja   Merkord Jutta   Rohde Helga   Hinz Burkhard  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2162-2174

Springer Publishing Company

Access to resources Recommend Favorite

Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw

By Costa Barbara   Colleoni Mariapia   Conti Silvia   Parolaro Daniela   Franke Chiara   Trovato Anna   Giagnoni Gabriella  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 3, 2004-03 ,pp. : 294-299

Springer Publishing Company

Access to resources Recommend Favorite